ESSA Pharma Inc
NASDAQ:EPIX
ESSA Pharma Inc
Pre-Tax Income
ESSA Pharma Inc
Pre-Tax Income Peer Comparison
Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors
Company | Pre-Tax Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
ESSA Pharma Inc
NASDAQ:EPIX
|
Pre-Tax Income
-$25.8m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
|
Zymeworks Inc
NYSE:ZYME
|
Pre-Tax Income
-$119.2m
|
CAGR 3-Years
13%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
N/A
|
|
Repare Therapeutics Inc
NASDAQ:RPTX
|
Pre-Tax Income
-$103.2m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
-49%
|
CAGR 10-Years
N/A
|
|
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
|
Pre-Tax Income
-$94.1m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-52%
|
CAGR 10-Years
N/A
|
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
Pre-Tax Income
-$77.5m
|
CAGR 3-Years
9%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-28%
|
|
Spectral Medical Inc
TSX:EDT
|
Pre-Tax Income
-CA$15.5m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-44%
|
CAGR 10-Years
-3%
|
See Also
What is ESSA Pharma Inc's Pre-Tax Income?
Pre-Tax Income
-25.8m
USD
Based on the financial report for Dec 31, 2023, ESSA Pharma Inc's Pre-Tax Income amounts to -25.8m USD.
What is ESSA Pharma Inc's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 5Y
-16%
Over the last year, the Pre-Tax Income growth was 21%. The average annual Pre-Tax Income growth rates for ESSA Pharma Inc have been -1% over the past three years , -16% over the past five years .